Navigation Links
PharmAthene Announces Closing of $15 Million Public Offering
Date:11/3/2010

, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The securities may be offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. Copies of the prospectus and the final prospectus supplement may be obtained at the Securities and Exchange Commission's website at http://www.sec.gov/. Copies of the prospectus and the final prospectus supplement may also be obtained from Roth Capital Partners, LLC Syndicate Department, 24 Corporate Plaza, Newport Beach, CA 92660, at 800-678-9147 and Rothecm@roth.com.

About PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:

  • SparVax™ - a second generation recombinant protective antigen (rPA) anthrax vaccine
  • Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection
  • rBChE - recombinant butyrylcholinesterase bioscavanger: Protexia®  and a second generation Advanced Expression System ("AES") countermeasures for nerve agent poisoning by organophosphate compounds, including nerve gases and pesticides

Statement on Cautionary Factors

Except for the historical information presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are no
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PharmAthene Appoints Eric I. Richman President and Chief Executive Officer
2. PharmAthene Provides Update on NYSE Amex Listing Compliance Plan
3. PharmAthene Completes Previously Announced Registered Direct Offering
4. PharmAthene Presents New Data for Lyophilized rPA Anthrax Vaccine Showing Enhanced Immunogenicity
5. PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health
6. PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop
7. PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop
8. PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
9. PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
10. PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program
11. PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... ALTO, Calif. , Sept. 30, 2014 /PRNewswire/ ... investment group focused on supporting promising emerging biotech, ... has been named the Top Angel Investment Group ... Insights as the best performer out of 370 ... included: historical performance, network strength (connections), selection aptitude ...
(Date:9/30/2014)... 2014  Millennium Healthcare Inc. ( MHCC ) today announced ... a sales, marketing and distribution agreement with MDbizWorx. ... based provider of ancillary medical services that serves ... hospitals through a seasoned national marketing and sales ... Purchasing Accounts that include a network database of ...
(Date:9/30/2014)... DUBAI , UAE, September 30, 2014 ... Pharmacy branch openings to feature in-store events will change ...   Revolutionizing the way we use and ... customers interact with pharmacies. By catering to the very ... has designed a calendar of in-store events with various ...
Breaking Medicine Technology:Life Science Angels Ranked the Top Angel Investment Group in the U.S. 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 3Millennium Healthcare Secures New Sales, Marketing and Distribution Agreement 2Millennium Healthcare Secures New Sales, Marketing and Distribution Agreement 3Health First Pharmacy Redefines 'Pharmacy Retail Experience' 2Health First Pharmacy Redefines 'Pharmacy Retail Experience' 3
... 11 In conjunction with its fourth quarter 2009 earnings release (expected ... (NYSE: CVD ) is pleased to invite you to listen ... the Internet on Thursday, January 28, 2010 at 9:00 a.m. ET. , ... and Slide Presentation, When: January 28, 2010, 9:00 ...
... 11 BD (Becton, Dickinson and Company) (NYSE: BDX ... its first fiscal quarter 2010 earnings conference call on Thursday, January ... press release detailing the quarter,s earnings earlier that morning. , The ... accessible through BD,s website at www.bd.com/investors and will be ...
Cached Medicine Technology:BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call 2
(Date:9/30/2014)... September 30, 2014(BRONX, NY)Medications are the leading cause of ... analysis of death certificates from 1999 to 2010, conducted ... and Albert Einstein College of Medicine of Yeshiva ... Journal of Allergy and Clinical Immunology , also ... was particularly high among older people and African-Americans and ...
(Date:9/30/2014)... Vegas, NV (PRWEB) September 30, 2014 ... as a free introduction to SurvivalLife.com along with a free ... caught the attention of Shane Michaels, prompting an investigative review. ... most well-known people in the survival and preparation niche, and ... all of the great classes and survival products that Joe ...
(Date:9/30/2014)... September 30, 2014 The American ... to help diabetics curb their sweet tooth, but the ... this September, suggests that zero-calorie sweeteners may actually ... diabetes. , The Weizmann Institute of Science in ... artificial sweeteners to mice, the mice developed glucose intolerance. ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Hospice ... its annual “In Celebration” gala, honoring three outstanding ... mission of striving to provide extraordinary and dignified ... facing a serious or life-limiting illness. , The ... in Rye, NY and recognized William (Bill) J. ...
(Date:9/30/2014)... 2014 A group of Americans is headed ... epidemic that, left unchecked, could create a catastrophic, global pandemic. ... to Africa. John Rogers, the Executive Director the Eugene Bell ... fight a disease most think mankind conquered long ago: tuberculosis. ... ago is on the comeback in several countries - what’s ...
Breaking Medicine News(10 mins):Health News:Comprehensive Study of allergic deaths in US finds medications are main culprit 2Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2
... Center at the University of California, San Diego, the University ... how a gene alteration can lead to the development of ... compound that could staunch the cancer,s growth. , The researchers, ... UC San Diego School of Medicine, have shown that when ...
... For decades, researchers have evaluated the thermal performance of ... current interest is how to address the burns received ... with fire - called stored heat burns. Researchers at ... and measurement protocol that allow firefighter suits to be ...
... to Enhance Tobacco-Related Research WASHINGTON, ... for Tobacco Research and Policy Studies at the ... Center at Georgetown University Medical Center ... Cancer Control Consortium. The consortium, formally agreed to ...
... nutritional benefits; Packaging now more environmentally responsibleNEW YORK, April ... the enhanced water category, PepsiCo (PEP) is re-launching ... beverage designed to help hydrate and nourish the body,s ... Propel is available in a variety of great-tasting ...
... findings at AMCP Conference in AprilST. PAUL, Minn., ... (Prime) revealed a significant reduction in inappropriate prescription ... drug utilization review (RetroDUR) program paired with a ... recently published in the American Journal of Geriatric ...
... recognition of April as National Autism Awareness Month, LoJack Corporation (Nasdaq: ... http://www.lojack.com/knowledge/Documents/AutismAwarenessMonth.mp3 ) that provided valuable information ... The rising incidence of autism in the ... of caring for an autistic child , ...
Cached Medicine News:Health News:Reversing effects of altered enzyme may fight brain tumor growth 2Health News:NC State develops new test method to measure stored heat in firefighter suits 2Health News:American Legacy Foundation(R) and Georgetown University Medical Center Create Research Collaboration 2Health News:American Legacy Foundation(R) and Georgetown University Medical Center Create Research Collaboration 3Health News:American Legacy Foundation(R) and Georgetown University Medical Center Create Research Collaboration 4Health News:Propel Unveils New Enhanced Experience 2Health News:Propel Unveils New Enhanced Experience 3Health News:Drug Utilization Review Reveals Potentially Inappropriate Medication Use Among Elderly Population 2Health News:Drug Utilization Review Reveals Potentially Inappropriate Medication Use Among Elderly Population 3Health News:April is National Autism Awareness Month: LoJack Hosts Educational Podcast Featuring Panel of Experts Addressing Autism Issues 2
Straight shafts with 16 mm long platform. Lengthwise serrated jaws with cross serrated tips. Serrated handle with polished finish. Platform: 2.4 mm wide....
Straight shafts with 15 mm long jaws. Serrated handle with polished finish. Smooth jaws....
Straight shafts with 6.5 mm tying platform. Crisscross serrated 1mm tips. Scalloped handle with dull finish....
Smooth tip forceps allow the surgeon to manipulate and smooth the corneal flap in Lasik procedures. Tip angled 10 mm from tip. Manufactured in titanium....
Medicine Products: